Longevity PapersAbout
← All papers
RESEARCH PAPER / 2026-11-16

TIP60/KAT5-mediated regulation of apoptotic sensitivity during DNA damage-induced senescence

Dutta, S., Malaquin, N., Goy, E., Carrier- Leclerc, A., Cardin, G., Rodier, F.

Universite de Montreal · biorxiv

Abstract

Cellular senescence and apoptosis are two distinct outcomes to DNA damage. It is unclear what determines the fate decision and the characteristics of senescent cells. Chromatin modifiers are likely candidates, as they can influence the environment for repair of DNA double-strand breaks as well as the transcription of senescent genes. Here we report that the lysine acetyltransferase TIP60/KAT5 is a dosage-sensitive determinant of senescent cell identity in normal human fibroblasts. Although TIP60 is not required for the senescence-associated proliferation arrest of cells after a single dose of 10 Gy of ionising radiation, the resolution of 53BP1 and {gamma}H2AX foci as well as the amplitude of the senescence-associated secretory phenotype (SASP) as measured by transcript and protein levels of secreted factors is dependent on the levels of TIP60. Furthermore, the sensitivity of senescent cells to apoptosis is also modulated by TIP60 levels. Cells with low levels of TIP60 show reduced p53 output and high levels of the anti-apoptotic protein MCL-1 and are completely resistant to the senolytic ABT-263. Cells with high levels of TIP60 are modestly more sensitive to ABT-263. These results place TIP60 upstream of the divergence of senescent phenotypes and establish that proliferation arrest and the SASP are uncoupled by the level of a single chromatin modifier. We further identify TIP60 as a candidate determinant of senolytic / senomorphic response and suggest that MCL-1 co-inhibition could be used as a rational addition in contexts where TIP60 levels are low.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

TIP60/KAT5 dosage determines the divergence between senescent cell identity, SASP amplitude, and sensitivity to senolytic drugs like ABT-263. This is relevant because it identifies a specific chromatin modifier that uncouples proliferation arrest from the harmful secretory phenotype and senolytic resistance, offering a mechanistic basis for improving senolytic therapies which are a key strategy for extending healthspan.

Author of this paper? Send a correction.